P479: TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K

• Ton Falqués-Costa,
• Mattias Pilheden,
• Qirui Zhang,
• Louise Ahlgren,
• Helena Sturesson,
• Lars Rönnstrand,
• Axel Hyrenius-Wittsten,
• Julhash U. Kazi,
• Anna K. Hagström-Andersson

Affiliations

Ton Falqués-Costa

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden

Mattias Pilheden

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden

Qirui Zhang

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden

Louise Ahlgren

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden

Helena Sturesson

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden

Lars Rönnstrand

2 Lund University, Department of Laboratory Medicine - Division of Translational Cancer Research, Lund, Sweden

Axel Hyrenius-Wittsten

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden

Julhash U. Kazi

2 Lund University, Department of Laboratory Medicine - Division of Translational Cancer Research, Lund, Sweden

Anna K. Hagström-Andersson

1 Lund University, Department of Laboratory Medicine – Division of Clinical Genetics, Lund, Sweden